首页> 外文期刊>AIDS >Reactivation of hepatitis B virus replication during peginterferon-ribavirin therapy in an HIV/hepatitis C virus-co-infected patient with isolated anti-hepatitis B core antibodies.
【24h】

Reactivation of hepatitis B virus replication during peginterferon-ribavirin therapy in an HIV/hepatitis C virus-co-infected patient with isolated anti-hepatitis B core antibodies.

机译:在具有单独的抗乙型肝炎核心抗体的HIV /丙型肝炎病毒共感染患者中,聚乙二醇干扰素-利巴韦林治疗期间乙型肝炎病毒复制的重新激活。

获取原文
获取原文并翻译 | 示例
       

摘要

In a recent French national survey the prevalence of isolated anti-hepatitis B core (HBc) antibodies was estimated to be 37.6% among HIV-infected patients . It may be more frequent in individuals with hepatitis C-virus (HCV) co-infection . However, in HIV-seronegative patients with an 'anti-HBc alone' serological pattern, hepatitis B virus (HBV) DNA is detected in approximately 10% of cases and reactivation is rare .
机译:在法国最近的一项全国调查中,估计在HIV感染患者中,分离出的抗乙型肝炎核心(HBc)抗体的患病率为37.6%。在丙型肝炎病毒(HCV)合并感染的个体中可能更常见。但是,在具有“单独抗-HBc”血清学模式的HIV血清阴性患者中,大约10%的病例中检测到了乙型肝炎病毒(HBV)DNA,而且很少再激活。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号